5187.T - Create Medic Co., Ltd.

Tokyo - Tokyo Delayed Price. Currency in JPY
  • Dividend

    5187.T announced a cash dividend of 17.00 with an ex-date of Jun. 29, 2023

Create Medic Co., Ltd.

Yokohama 224-0037
81 45 943 2741

IndustryMedical Devices
Full Time Employees1,117

Key Executives

NameTitlePayExercisedYear Born
Mr. Hidenori TaniguchiPres & DirectorN/AN/A1960
Mr. Atsushi HashiiExec. Officer, Mang. of Overall Admin. Department & DirectorN/AN/A1955
Mr. Yozo AkaokaSr. MD & DirectorN/AN/A1961
Mr. Shinichi EndoExec. Officer & DirectorN/AN/A1963
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.


Create Medic Co., Ltd. researches, develops, manufactures, and sells medical appliances in Japan and internationally. The company offers disposable medical devices made of silicone resin. It provides various urology, gastroenterology, percutaneous endoscopic gastrostomy, and surgery products. The company also provides other products, such as CLINY tracheostomy tubes, endotracheal tubes, tracheostomy tubes, and microcatheters. In addition, it offers OEM products comprising multi-lumen tubes, ultrathin walls, profile extrusions, and special structures; special shape and high-volume low-pressure cuff moldings; and hydrophilic coating and needles, as well as the technology on an OEM basis. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. Create Medic Co., Ltd. was incorporated in 1974 and is headquartered in Yokohama, Japan.

Corporate Governance

Create Medic Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.